MedTrace Logo

Observational Prospective Study on Patients Treated With Norditropin®

NCT00960128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21249

Last updated 2017-10-12

No results posted yet for this study

Summary

This observational study is conducted globally. The aim of the study is to investigate the effectiveness and safety of real-life treatment with Norditropin®. The study population will consist of children and adults who are on treatment with Norditropin® in accordance with normal clinical practice.

Conditions

  • Growth Hormone Disorder
  • Growth Hormone Deficiency in Children
  • Adult Growth Hormone Deficiency
  • Genetic Disorder
  • Turner Syndrome
  • Foetal Growth Problem
  • Small for Gestational Age
  • Chronic Kidney Disease
  • Chronic Renal Insufficiency
  • Noonan Syndrome

Interventions

DRUG

somatropin

The effectiveness and safety data collection with the use of Norditropin® in daily clinical practice with adults.

DRUG

somatropin

The effectiveness and safety data collection with the use of Norditropin® in daily clinical practice with children.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-01
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Argentina
  • Belgium
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Hungary
  • Ireland
  • Israel
  • Italy
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Russia
  • Saudi Arabia
  • Serbia
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00960128 on ClinicalTrials.gov